Target c-Myc to treat pancreatic cancer

M Ala - Cancer biology & therapy, 2022 - Taylor & Francis
ABSTRACT C-Myc overexpression is a common finding in pancreatic cancer and predicts
the aggressive behavior of cancer cells. It binds to the promoter of different genes, thereby …

[HTML][HTML] Focus: the science of stress: oxidative stress and inflammation in cardiovascular diseases and cancer: role of non-coding RNAs

P Ginckels, P Holvoet - The Yale Journal of Biology and Medicine, 2022 - ncbi.nlm.nih.gov
Abstract High oxidative stress, Th1/Th17 immune response, M1 macrophage inflammation,
and cell death are associated with cardiovascular diseases. Controlled oxidative stress …

[HTML][HTML] Loss of miR-29a/b1 promotes inflammation and fibrosis in acute pancreatitis

S Dey, LM Udari, P RiveraHernandez, JJ Kwon… - JCI insight, 2021 - ncbi.nlm.nih.gov
Abstract MicroRNA-29 (miR-29) is a critical regulator of fibroinflammatory processes in
human diseases. In this study, we found a decrease in miR-29a in experimental and human …

[HTML][HTML] miRNAs in pancreatic cancer progression and metastasis

ETY Mok, JL Chitty, TR Cox - Clinical & Experimental Metastasis, 2024 - Springer
Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells.
Dysregulation of miRNA expression and function has been linked to a variety of diseases …

[HTML][HTML] MiR-29a-3p: A potential biomarker and therapeutic target in colorectal cancer

WY Mo, SQ Cao - Clinical and Translational Oncology, 2023 - Springer
Cancer is frequently caused by microRNAs, which control post-transcriptional levels of gene
expression by binding to target mRNAs. MiR-29a-3p has recently been shown to play a …

[HTML][HTML] Circ-sh3rf3/GATA-4/miR-29a regulatory axis in fibroblast–myofibroblast differentiation and myocardial fibrosis

CX Ma, ZR Wei, T Sun, MH Yang, YQ Sun… - Cellular and Molecular …, 2023 - Springer
The transdifferentiation from cardiac fibroblasts to myofibroblasts is an important event in the
initiation of cardiac fibrosis. However, the underlying mechanism is not fully understood. Circ …

[HTML][HTML] LOXL2 in cancer: a two-decade perspective

A Cano, P Eraso, MJ Mazón, F Portillo - International Journal of Molecular …, 2023 - mdpi.com
Lysyl Oxidase Like 2 (LOXL2) belongs to the lysyl oxidase (LOX) family, which comprises
five lysine tyrosylquinone (LTQ)-dependent copper amine oxidases in humans. In 2003 …

[HTML][HTML] Towards an integrative understanding of cancer mechanobiology: calcium, YAP, and microRNA under biophysical forces

C Liang, M Huang, T Li, L Li, H Sussman, Y Dai… - Soft Matter, 2022 - pubs.rsc.org
An increasing number of studies have demonstrated the significant roles of the interplay
between microenvironmental mechanics in tissues and biochemical-genetic activities in …

[HTML][HTML] Multiple roles of LOXL2 in the progression of hepatocellular carcinoma and its potential for therapeutic targeting

J Radić, B Kožik, I Nikolić, I Kolarov-Bjelobrk… - International Journal of …, 2023 - mdpi.com
LOXL2, a copper-dependent amine oxidase, has emerged as a promising therapeutic target
in hepatocellular carcinoma (HCC). Increased LOXL2 expression in HCC has been linked …

[HTML][HTML] The emerging role of microRNAs and autophagy mechanism in pancreatic cancer progression: future therapeutic approaches

E Koustas, EM Trifylli, P Sarantis, N Papadopoulos… - Genes, 2022 - mdpi.com
Pancreatic cancer constitutes the fourth most frequent cause of death due to malignancy in
the US. Despite the new therapeutic modalities, the management of pancreatic ductal …